Psychemedics Corporation (NASDAQ:PMD) Getting Very Positive Media Coverage, Analysis Finds

Media coverage about Psychemedics Corporation (NASDAQ:PMD) has trended very positive on Sunday, Accern reports. The research firm rates the sentiment of news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Psychemedics Corporation earned a media sentiment score of 0.52 on Accern’s scale. Accern also assigned media headlines about the company an impact score of 90 out of 100, indicating that recent news coverage is very likely to have an effect on the company’s share price in the near term.

Psychemedics Corporation (PMD) traded up 2.34% on Friday, reaching $26.70. The company had a trading volume of 52,322 shares. Psychemedics Corporation has a 52-week low of $13.81 and a 52-week high of $27.99. The stock has a 50 day moving average price of $24.61 and a 200 day moving average price of $22.00. The stock has a market capitalization of $145.78 million, a PE ratio of 17.92 and a beta of 1.00.

ILLEGAL ACTIVITY NOTICE: “Psychemedics Corporation (NASDAQ:PMD) Getting Very Positive Media Coverage, Analysis Finds” was published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark and copyright legislation. The legal version of this piece can be viewed at https://www.chaffeybreeze.com/2017/07/30/very-favorable-news-coverage-very-likely-to-impact-psychemedics-corporation-nasdaqpmd-share-price-updated-updated-updated.html.

Psychemedics Corporation Company Profile

Psychemedics Corporation (Psychemedics) provides hair testing for drugs of abuse, utilizing a hair analysis method involving digestion of hair, enzyme immunoassay (EIA) technology and confirmation by mass spectrometry to analyze human hair to detect abused substances. The Company operates in drug testing services segment.

Insider Buying and Selling by Quarter for Psychemedics Corporation (NASDAQ:PMD)

Receive News & Ratings for Psychemedics Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Psychemedics Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply